2/ This cross-sectional population-based survey included a convenience sample of 37,000 kids & adults in King County, Washington, who enrolled online for home self-collection of upper respiratory samples for SARS-CoV-2 testing from Mar-Nov 2020
3/ 37,067 samples were tested & 673 (1.8%) were #sarscov2 positive (1.6% in adults, 3.4% in kids)
Most kids (80%) had a known SARS-CoV-2 +ve contact, & most contacts (68%) were in the same household
But only 41% of SARS-CoV-2 +ve adults (41.4%) reported any known +ve contact
4/ Among 555 SARS-CoV-2–positive participants, 47/123 (38%) kids were asymptomatic vs 31/432 (7%) adults
Also, asymptomatic children were younger than symptomatic children (mean [SD] age, 6.2 [4.5] years vs 8.3 [5.7] years; P < .001)
👉younger kids less likely to have symptoms
5/ When symptomatic, fewer symptoms were reported in kids vs adults
(mean number of symptoms [SD], 1.6 [2.0] vs 4.5 [3.1])
The duration of symptoms was also shorter in kids than in adults
(mean (SD) of 3.8 (3.8) days of symptoms vs 4.9 (4.1) days in symptomatic adults)
6/ The most common signs & symptoms in kids were runny or stuffy nose, fever, headache, and cough, while adults most frequently reported headache, cough, & fatigue
Note that this study was done before the Alpha or Delta variant was circulating in the US
7/ Co-infection with other viruses was rare
Of 555 SARS-CoV-2 +ve swabs, 487 were tested for 24 respiratory pathogens by RT-PCR. Only 3/108 kids (2.8%) had another virus (2 rhinovirus, 1 adenovirus) vs 10/379 adults (2.6%): 7 rhinovirus, 1 adenovirus, 1 enterovirus, 1 influenza
8/ Symptomatic individuals had lower Ct values (corresponding to higher viral RNA levels) than asymptomatic individuals
Also, Ct values (virus levels) were not significantly different btwn symptomatic kids & symptomatic adults or between asymptomatic kids & asymptomatic adults
9/ Accompanying editorial summarises findings & implications in detail
👉 Take home message: children were less frequently symptomatic, had fewer symptoms & shorter duration of symptoms vs adults - all likely to contribute to lower risk of transmission
1/ Household transmission of #SARSCoV2 in children & adults
This new @PHE_uk study was pre-Alpha, pre-Delta & pre-vaccine but provides important insight into household infection & transmission risks in kids & adults
1/ How long do 2 doses of #COVID19 vaccines protect for? Who needs booster vaccinations?
Our team @phe_uk have just published a pre-print on vaccine effectiveness (VE) and duration of protection after 2 doses of Pfizer and AZ vaccines in adults … 🧵
2/ We now have data for ~6 months post-vaccination & compare VE by age, comorbidity & #sarscov2 strain (Alpha/Delta)
We used a test-negative case-control design to estimate VE after 2 doses against PCR-confirmed disease, hospitalisation within 14d of PCR test & death within 28d
3/ In this analysis, 2 million adults (38.7%) had 2x AZ, 1.7 million (31.7%) had 2x Pfizer, 124k (2.4%) had 2x Moderna & 10k (0.2%) had mixed/other
There were 1.5 million cases (544k Alpha, 895k Delta, 37k other/unknown) & 3.8 million negative tests from 3.3 million adults
1/ Our paper on #SARSCoV2 infection, seroconversion and antibody positivity rates in English secondary schools following the emergence of the Alpha variant (B.1.1.7) is now online.
2/ We tested #SARSCoV2 infection and serum antibodies in nearly 2,000 staff and students attending 18 secondary schools in 6 English regions during Sep 2020, Dec 2020 and March 2021. Most students did not return to school after the Christmas holidays until their tests in Mar 2021
3/ In March 2021, 1895 participants (1100 students:795 staff) were tested; 5.6% (61/1094) students and 4.4% (35/792) staff had laboratory-confirmed SARS-CoV-2 infection from December 2020-March 2021
1/ Following a barrage of Twitter abuse because of my quote about our School Infection Survey (SIS) results today, I would like to reiterate what we have learnt about #COVID19 after 9 million students returned to full-time in-person education in England in March this year 👇
2/ The UK went into national lockdown including school closures in Jan 2021 following emergence of the Alpha variant. #COVID19 cases declined rapidly & schools reopened fully on 08 Mar 2021 (wk 10) when the rest of England remained in lockdown 👉 gov.uk/government/sta…
3/ During the 3 weeks until Easter holidays (wks 10-13, black circle), we saw a small ⬆️ in #covid19 cases among primary school kids (red line) & (because of mass rapid antigen testing before schools reopening) a large short-lived spike in secondary school kids (green) 👇
1/ There have been increasing claims, mainly in North American news outlets, that the #SARSCoV2 DELTA variant is causing more severe #COVID19 in kids compared to previous variants
Well, everything we know so far indicates that’s it’s *not* true. Here’s why…🧵
2/ It’s true that the delta variant is more transmissible the both the alpha variant & the original strains, which means that it will infect more people more quickly, but there is no evidence that the risk of infection or transmission to others is different in kids vs adults
3/ Because of its higher transmissibility, there will be more Delta variant cases &, since most adults in many countries are vaccinated against #COVID19, cases/hospitalisations may seem disproportionately ⬆️ in kids (especially teens) vs adults. This just shows that #VaccinesWork
1/ It’s actually headline-grabbing news articles such as this that fuel conspiracy theories
The JCVI did not make a U-turn on vaccinating teens. The JCVI path to vaccinating teens has remained the same & their message has been consistent. Here’s why 🧵
2/ On 19 July 2021, JCVI issued advice on COVID-19 vaccination for teenagers
JCVI advised that those aged 12+ years with specific underlying health conditions that put them at risk of serious COVID-19 should be offered COVID-19 vaccination
3/ For healthy teens, however, JCVI *deferred* the decision, specifically stating “Data on the incidence of these events [myocarditis in teens & young adults] are currently limited, & the longer-term health effects from the myocarditis events reported are not yet well understood”